SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001628280-18-001351
Filing Date
2018-02-09
Accepted
2018-02-09 16:54:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G - AJ KAZIMI 2017 sch13g-ajkazimi2017.htm SC 13G 76449
  Complete submission text file 0001628280-18-001351.txt   77944
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filed by) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-85205 | Film No.: 18592567
SIC: 2834 Pharmaceutical Preparations